Under the title “Holistic pro-Inflammatory Target for Sight (HITS)” the Ophthalmology Pivotal Meeting kicked off in Saudi ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with ...

As of March 31, 2025, the Company's cash, cash equivalents and investments was $314.2 million. The Company expects that its ...

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...

Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

Addex Therapeutics partner Indivior advances GABAB positive allosteric modulator programme successfully through IND enabling studies: Geneva, Switzerland Tuesday, May 13, 2025, 15 ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio ...

Investing.com -- Citi has expanded its biopharmaceutical research coverage ... clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies ...